Fri, March 5, 2021
Thu, March 4, 2021
Wed, March 3, 2021

Nathan Weinstein Initiated (CDTX) at Strong Buy and Held Target at $180 on, Mar 4th, 2021

Nathan Weinstein of Aegis Capital, Initiated "Cidara Therapeutics, Inc." (CDTX) at Strong Buy and Held Target at $180 on, Mar 4th, 2021.

Nathan, nor any peers, have made any analyst calls on CDTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30